Not available
Quote | Summit Therapeutics Inc. (NASDAQ:SMMT)
Last: | $3.55 |
---|---|
Change Percent: | 1.95% |
Open: | $3.52 |
Close: | $3.55 |
High: | $3.62 |
Low: | $3.44 |
Volume: | 1,407,115 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
News | Summit Therapeutics Inc. (NASDAQ:SMMT)
2024-04-25 17:49:16 ET Summary The Annual Meeting of the American Society of Clinical Oncology is a major event for clinicians and researchers in the field of oncology. The plenary session will feature presentations on topics such as esophageal cancer, melanoma, and lung cancer. ...
Conference Call to be Held at 9:00am ET Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) will host an earnings call to announce its first quarter 2024 financial results and provide an operational update for the Company ...
Message Board Posts | Summit Therapeutics Inc. (NASDAQ:SMMT)
Subject | By | Source | When |
---|---|---|---|
znewcar1: $SMMT Hod2.01 RL1.6 | znewcar1 | investorshangout | 05/05/2023 2:49:05 PM |
znewcar1: $SMMT Hod1.75 ML1.3 hard pull off 1.6 | znewcar1 | investorshangout | 05/03/2023 4:54:09 PM |
whytestocks: $SMMT News Article - Summit Therapeutics Announces Initial Indications for Clinical Tri | whytestocks | investorshangout | 05/03/2023 3:55:49 PM |
znewcar1: $SMMT Lod1.33 double bottom? How low does it go? | znewcar1 | investorshangout | 04/26/2023 2:15:23 PM |
I agree. | NRS | investorshub | 04/25/2023 6:21:45 PM |
News, Short Squeeze, Breakout and More Instantly...
Summit Therapeutics Inc. Company Name:
SMMT Stock Symbol:
NASDAQ Market:
Conference Call to be Held at 9:00am ET Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) will host an earnings call to announce its first quarter 2024 financial results and provide an operational update for the Company ...
Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that Mostafa Ronaghi, PhD, has been appointed to its Board of Directors, effective immediately. “We are excited to add Dr. Ronaghi to complement our exce...
Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that it will participate in and present at the Stifel 2024 Targeted Oncology Forum, which will be held virtually April 16-17, 2024. Dr. Maky Zanganeh, Chief Executi...